2009
DOI: 10.1016/j.thromres.2008.12.030
|View full text |Cite
|
Sign up to set email alerts
|

Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease

Abstract: Introduction-Chronic obstructive pulmonary disease (COPD) patients have increased risk for cardiovascular mortality and venous thromboembolism. Tissue factor (TF) is the physiological initiating mechanism for blood coagulation and is pro-inflammatory.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
51
0
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 63 publications
(56 citation statements)
references
References 20 publications
3
51
0
2
Order By: Relevance
“…The F3 gene encodes coagulation factor III, a cell surface glycoprotein with major roles in initiating the blood coagulation cascade, chemokine production, 25 pro-inflammatory effects and innate immunity. 25,26 There is no experimental data to support the assumption that methylation in F3 promoter regulates the gene. However, the sequence we analyzed was previously suggested to have that role based on sequence characteristics.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The F3 gene encodes coagulation factor III, a cell surface glycoprotein with major roles in initiating the blood coagulation cascade, chemokine production, 25 pro-inflammatory effects and innate immunity. 25,26 There is no experimental data to support the assumption that methylation in F3 promoter regulates the gene. However, the sequence we analyzed was previously suggested to have that role based on sequence characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…28,29 Consistent with our results, higher F3 levels in whole blood have been shown in patients with COPD compared with healthy subjects. 26 Moreover, inflammation also promotes coagulation which accentuates the (POU2F2, BCL3, STAT1, PU.1, SP1, Inil, EBF1, HEY1, BATF, BAF155, TAF1 and STS2). This might help to explain the differences we saw between position 3 and positions 1-2 (Table S4).…”
mentioning
confidence: 99%
“…Whether this increased velocity of shortening is innate or acquired due to asthma in humans remains to be determined. Two mechanisms have been suggested to be responsible for the observed increased velocity of shortening in asthmatic ASM: 1-The increased expression of myosin light chain kinase (MLCK) (3,16,133); and 2-a preponderant expression of the faster cycling smooth muscle myosin heavy chain (smMHC) isoform B over the slower cycling smMHC isoform A (reviewed in (132)). MLCK is a enzyme capable of phosphorylating the regulatory myosin light chain (rMLC), which is a necessary step required for actin-activation of myosin ATPase activity and the subsequent binding and pivotal of the cross-bridges on the actin filaments.…”
Section: Tolerance To Oscillating Stretches and Rate Of Recovery Follmentioning
confidence: 99%
“…In accordance to this assertion, the ratio of the isoforms correlates with the level of airway responsiveness in rats; i.e., hyperresponsive animals expressed more of the B than the normo-responsive animals (73). The mRNA expression of the B isoform is also overexpressed in human asthmatics (133). Taken together, the amount and the velocity of shortening are potentially important factors determining the level of airway responsiveness.…”
Section: Tolerance To Oscillating Stretches and Rate Of Recovery Follmentioning
confidence: 99%
See 1 more Smart Citation